Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12394779 | 0.96 | MEN1 (0.76) | MEN1KMT2ATDP1POLBHSP90AA1 | |
| SCHEMBL11303120 | 0.93 | MEN1 (0.77) | MEN1KMT2ATDP1POLBHSP90AA1 | |
| SCHEMBL1964298 | 0.88 | MEN1 (0.57) | MEN1KMT2ATDP1POLBHSP90AA1 | |
| SCHEMBL12418678 | 0.88 | MEN1 (0.56) | MEN1KMT2ATDP1POLBHSP90AA1 | |
| SCHEMBL13447835 | 0.87 | MEN1 (0.56) | MEN1KMT2ATDP1POLBHSP90AA1 | |
| SCHEMBL13447836 | 0.85 | KMT2A (0.57) | MEN1KMT2ATDP1POLBHSP90AA1 | |
| SCHEMBL36911 | 0.85 | MEN1 (1.00) | MEN1KMT2ATDP1POLBHSP90AA1 | |
| SCHEMBL22609989 | 0.85 | MEN1 (1.00) | MEN1KMT2ATDP1POLBHSP90AA1 | |
| SCHEMBL912888 | 0.85 | MEN1 (1.00) | MEN1KMT2ATDP1POLBHSP90AA1 | |
| SCHEMBL68549 | 0.85 | MEN1 (1.00) | MEN1KMT2ATDP1POLBHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110172097-A1 | Imidazole and Triazole Compounds, Their Use and Agents Containing The Same | BASF SE (DE) | 2011-07-14 | — | — | US | disclosed |
| US-20110172097-A1 | Imidazole and Triazole Compounds, Their Use and Agents Containing The Same | BASF SE (DE) | 2011-07-14 | — | — | US | disclosed |
| WO-2010031848-A1 | IMIDAZOLE AND TRIAZOLE COMPOUNDS, THEIR USE AND AGENTS CONTAINING THE SAME | BASF SE (DE) | 2010-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172097-A1 | Imidazole and Triazole Compounds, Their Use and Agents Containing The Same | COX4I1, CYP2C19, CYP3A43 | MEN1 986/4885KMT2A 1323/4885TDP1 688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.